InsidersTradesSigma
Track the Tvardi Therapeutics, Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €16.6m. The latest transaction was reported on 5 August 2025 (J). Among the most active insiders: HALL WALLACE L JR. The full history is free.
Analysts rate Tvardi Therapeutics, Inc. Buy (bullish), based on 8 analysts. Average price target: US$8.50.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Tvardi Therapeutics, Inc. 是一家生物制药公司，专注于开发治疗严重疾病的创新疗法。它专门从事靶向疗法的发现和商业化。